News
An eight-member panel voted unanimously against wider use of Pfizer’s Talzenna in advanced prostate cancer. Elsewhere, U.K.
A Massachusetts-based wound care and sports medicine company announced plans for its brand-new biomanufacturing facility ...
Who's giving a half-billion-dollar jolt to Power Station project? © 2025 American City Business Journals. All rights reserved ...
The incarcerated former Silicon Valley star is advising her partner on a new health tech startup. Holmes was convicted of ...
Biotechnology is a broad discipline in which biological processes, organisms, cells or cellular components are exploited to develop new technologies. New tools and products developed by ...
According to Ukrainian President, Volodymyr Zelensky, air defence systems remain active, as “dozens more drones are still in our skies.” In what Ukrainian officials describe as “one of the ...
A TOURIST DESTINATION. THE DEPARTMENT OF EDUCATION IS BACK TO REPORTING DEFAULTED LOANS TO COLLECTION AGENCIES. NOW, WITHIN THE COMING WEEKS, PEOPLE COULD HAVE SOME OF THEIR WAGES OR INCOME TAKEN ...
The FDA has freed Amgen’s mysterious early-stage obesity asset from a clinical hold, with the phase 1 study now enrolling participants. The historically tight-lipped Amgen execs remain judicious ...
1511 ET – U.S. natural gas futures resume their recovery from a four-week selloff, rising for the fourth time in five sessions even as a predicted switch to an inventory surplus is confirmed.
With exemptions under the U.S.-Mexico-Canada agreement confirmed, the company said it feels confident to resume forecasts.
The trial for a man accused of killing a La Salle High School graduate during an attempted robbery is scheduled to resume Thursday.Investigators say Luke Macke was lured into Westwood to be robbed ...
The offers received by Acelyrin include Concentra Biosciences’ attempt to buy the biotech for $3 a share. Acelyrin rejected that takeover bid in March. Tang Capital Partners, an investment firm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results